235 related articles for article (PubMed ID: 15160539)
1. Serum concentrations of sex hormones in men with severe lower urinary tract symptoms and benign prostatic hyperplasia.
Tan MO; Karabiyik I; Uygur MC; Diker Y; Erol D
Int Urol Nephrol; 2003; 35(3):357-63. PubMed ID: 15160539
[TBL] [Abstract][Full Text] [Related]
2. Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function. The Prostate Study Group of the Austrian Society of Urology.
Schatzl G; Brössner C; Schmid S; Kugler W; Roehrich M; Treu T; Szalay A; Djavan B; Schmidbauer CP; Söregi S; Madersbacher S
Urology; 2000 Mar; 55(3):397-402. PubMed ID: 10699620
[TBL] [Abstract][Full Text] [Related]
3. A possible relationship between serum sex hormones and benign prostatic hyperplasia/lower urinary tract symptoms in men who underwent transurethral prostate resection.
Wu Y; Pan H; Wang WM; Xu D; Zhang L; Gu ZQ; Bai Q; Qi J; Huang HF
Asian J Androl; 2017; 19(2):230-233. PubMed ID: 26763548
[TBL] [Abstract][Full Text] [Related]
4. Plasma steroid and protein hormone concentrations in patients with benign prostatic hypertrophy and in normal men.
Ortega E; Ruiz E; Mendoza MC; Martin-Andres A; Osorio C
Experientia; 1979 Jun; 35(6):844-5. PubMed ID: 89045
[TBL] [Abstract][Full Text] [Related]
5. Hormone blood levels and their inter-relationships in normal men and men with benign prostatic hyperplasia (BPH).
Bartsch W; Becker H; Pinkenburg FA; Krieg M
Acta Endocrinol (Copenh); 1979 Apr; 90(4):727-36. PubMed ID: 86267
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia.
Cochran RC; Ewing LL; Niswender GD
Invest Urol; 1981 Nov; 19(3):142-7. PubMed ID: 6170603
[TBL] [Abstract][Full Text] [Related]
7. Hormone concentration, metabolic disorders and immunoexpression of androgen and estrogen-alpha receptors in men with benign prostatic hyperplasia and testosterone deficiency syndrome.
Ryl A; Rotter I; Slojewski M; Dolegowska B; Grabowska M; Baranowska-Bosiacka I; Laszczynska M
Folia Histochem Cytobiol; 2015; 53(3):227-35. PubMed ID: 26400665
[TBL] [Abstract][Full Text] [Related]
8. Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.
Kristal AR; Schenk JM; Song Y; Arnold KB; Neuhouser ML; Goodman PJ; Lin DW; Stanczyk FZ; Thompson IM
Am J Epidemiol; 2008 Dec; 168(12):1416-24. PubMed ID: 18945688
[TBL] [Abstract][Full Text] [Related]
9. Relationship between lower urinary tract symptoms and serum levels of sex hormones in men with symptomatic benign prostatic hyperplasia.
Favilla V; Cimino S; Castelli T; Madonia M; Barbagallo I; Morgia G
BJU Int; 2010 Dec; 106(11):1700-3. PubMed ID: 20575982
[TBL] [Abstract][Full Text] [Related]
10. Comparison between selected hormone and protein levels in serum and prostate tissue homogenates in men with benign prostatic hyperplasia and metabolic disorders.
Grzesiak K; Rył A; Baranowska-Bosiacka I; Rotter I; Dołęgowska B; Słojewski M; Sipak-Szmigiel O; Ratajczak W; Lubkowska A; Metryka E; Piasecka M; Laszczyńska M
Clin Interv Aging; 2018; 13():1375-1382. PubMed ID: 30122909
[TBL] [Abstract][Full Text] [Related]
11. Sex steroids in serum and prostatic tissue of human cancerous prostate (STERKPROSER trial).
Meunier ME; Neuzillet Y; Raynaud JP; Radulescu C; Ghoneim T; Fiet J; Giton F; Rouanne M; Dreyfus JF; Lebret T; Botto H
Prostate; 2019 Feb; 79(3):272-280. PubMed ID: 30370569
[TBL] [Abstract][Full Text] [Related]
12. [Pre- and post-prostatectomy variation and supplement of sexual hormones in patients with benign prostatic hyperplasia].
Ren XM; Ying J; Yao DH; Jiang YQ; Xu MX
Zhonghua Nan Ke Xue; 2005 Jan; 11(1):50-2, 55. PubMed ID: 15704683
[TBL] [Abstract][Full Text] [Related]
13. Endocrine patterns in patients with benign and malignant prostatic diseases.
Schatzl G; Reiter WJ; Thürridl T; Waldmüller J; Roden M; Söregi S; Madersbacher S
Prostate; 2000 Aug; 44(3):219-24. PubMed ID: 10906738
[TBL] [Abstract][Full Text] [Related]
14. Relationship between serum sex hormones levels and degree of benign prostate hyperplasia in Chinese aging men.
Zeng QS; Xu CL; Liu ZY; Wang HQ; Yang B; Xu WD; Jin TL; Wu CY; Huang G; Li Z; Wang B; Sun YH
Asian J Androl; 2012 Sep; 14(5):773-7. PubMed ID: 22751417
[TBL] [Abstract][Full Text] [Related]
15. Serum sex steroids, gonadotrophins and sex hormone-binding globulin in prostatic hyperplasia.
Ansari MA; Begum D; Islam F
Ann Saudi Med; 2008; 28(3):174-8. PubMed ID: 18500180
[TBL] [Abstract][Full Text] [Related]
16. Impact of radical prostatectomy and TURP on the hypothalamic-pituitary-gonadal hormone axis.
Madersbacher S; Schatzl G; Bieglmayer C; Reiter WJ; Gassner C; Berger P; Zidek T; Marberger M
Urology; 2002 Nov; 60(5):869-74. PubMed ID: 12429318
[TBL] [Abstract][Full Text] [Related]
17. Serum hormone levels in benign prostatic hyperplasia.
Sköldefors H; Blomstedt B; Carlström K
Scand J Urol Nephrol; 1978; 12(2):111-4. PubMed ID: 80820
[TBL] [Abstract][Full Text] [Related]
18. Sex hormone profiles in oligomenorrheic adolescent girls and the effect of oral contraceptives.
Siegberg R; Nilsson CG; Stenman UH; Widholm O
Fertil Steril; 1984 Jun; 41(6):888-93. PubMed ID: 6233177
[TBL] [Abstract][Full Text] [Related]
19. Association between lower urinary tract symptoms and serum levels of sex hormones in men.
Miwa Y; Kaneda T; Yokoyama O
Urology; 2008 Sep; 72(3):552-5. PubMed ID: 18597822
[TBL] [Abstract][Full Text] [Related]
20. Plasma estradiol, free testosterone, sex hormone binding globulin binding capacity, and prolactin in benign prostatic hyperplasia and prostatic cancer.
Rannikko S; Adlercreutz H
Prostate; 1983; 4(3):223-9. PubMed ID: 6189106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
